Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women

doi:10.4330/wjc.v13.i5.130

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7004)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

289

WORD

165

HTML

2292

Figures (1-1)

337

Tables (1-7)

327

Sum=3410

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

413

Download

1044

Sum=1457

Publishing Process of This Article

Item

Count

Browse

605

Download

1532

Sum=2137

May 26, 2021 (publication date) through Feb 2, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Cardiol. May 26, 2021; 13(5): 130-143
Published online May 26, 2021. doi: 10.4330/wjc.v13.i5.130

Open in New Tab Full Size Figure Download Figure

Figure 1 Plasma concentrations (pg/mL) of soluble receptor for advanced glycation end products. Group I included coronary artery disease cases and Group II included healthy controls. sRAGE: Soluble receptor for advanced glycation end products.

Citation: Ghosh S, Kapoor D, Vijayvergiya R, Sangwan S, Wangkheimayum S, Mehta S, Dhawan V. Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women. World J Cardiol 2021; 13(5): 130-143
URL: https://www.wjgnet.com/1949-8462/full/v13/i5/130.htm
DOI: https://dx.doi.org/10.4330/wjc.v13.i5.130